Global Chronic Obstructive Pulmonary Disorder Market Professional Survey Report 2017

May 2017 | 111 pages | ID: G2B324CB46AEN
QYResearch

Abstracts

This report studies Chronic Obstructive Pulmonary Disorder in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• AstraZeneca
• Boehringer Ingelheim
• GSK
• Novartis
• Teva Pharmaceuticals
• Ache Laboratorios Farmaceuticos
• Almirall
• Aquinox Pharmaceuticals
• Ario Pharma
• Asmacure
• Astellas Pharma
• BioMarck Pharmaceuticals

By types, the market can be split into

• Short-Acting Bronchodilators
• Corticosteroids
• Methylxanthines
• Long-Acting Bronchodilators
• Phosphodiesterase-4 Inhibitors

By Application, the market can be split into

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Chronic Obstructive Pulmonary Disorder Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF CHRONIC OBSTRUCTIVE PULMONARY DISORDER

1.1 Definition and Specifications of Chronic Obstructive Pulmonary Disorder
  1.1.1 Definition of Chronic Obstructive Pulmonary Disorder
  1.1.2 Specifications of Chronic Obstructive Pulmonary Disorder
1.2 Classification of Chronic Obstructive Pulmonary Disorder
  1.2.1 Short-Acting Bronchodilators
  1.2.2 Corticosteroids
  1.2.3 Methylxanthines
  1.2.4 Long-Acting Bronchodilators
  1.2.5 Phosphodiesterase-4 Inhibitors
1.3 Applications of Chronic Obstructive Pulmonary Disorder
  1.3.1 Hospital Pharmacies
  1.3.2 Retail Pharmacies
  1.3.3 Online Pharmacies
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF CHRONIC OBSTRUCTIVE PULMONARY DISORDER

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Chronic Obstructive Pulmonary Disorder
2.3 Manufacturing Process Analysis of Chronic Obstructive Pulmonary Disorder
2.4 Industry Chain Structure of Chronic Obstructive Pulmonary Disorder

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF CHRONIC OBSTRUCTIVE PULMONARY DISORDER

3.1 Capacity and Commercial Production Date of Global Chronic Obstructive Pulmonary Disorder Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Chronic Obstructive Pulmonary Disorder Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Chronic Obstructive Pulmonary Disorder Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Chronic Obstructive Pulmonary Disorder Major Manufacturers in 2016

4 GLOBAL CHRONIC OBSTRUCTIVE PULMONARY DISORDER OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global Chronic Obstructive Pulmonary Disorder Capacity and Growth Rate Analysis
  4.2.2 2016 Chronic Obstructive Pulmonary Disorder Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global Chronic Obstructive Pulmonary Disorder Sales and Growth Rate Analysis
  4.3.2 2016 Chronic Obstructive Pulmonary Disorder Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global Chronic Obstructive Pulmonary Disorder Sales Price
  4.4.2 2016 Chronic Obstructive Pulmonary Disorder Sales Price Analysis (Company Segment)

5 CHRONIC OBSTRUCTIVE PULMONARY DISORDER REGIONAL MARKET ANALYSIS

5.1 North America Chronic Obstructive Pulmonary Disorder Market Analysis
  5.1.1 North America Chronic Obstructive Pulmonary Disorder Market Overview
  5.1.2 North America 2012-2017E Chronic Obstructive Pulmonary Disorder Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E Chronic Obstructive Pulmonary Disorder Sales Price Analysis
  5.1.4 North America 2016 Chronic Obstructive Pulmonary Disorder Market Share Analysis
5.2 China Chronic Obstructive Pulmonary Disorder Market Analysis
  5.2.1 China Chronic Obstructive Pulmonary Disorder Market Overview
  5.2.2 China 2012-2017E Chronic Obstructive Pulmonary Disorder Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E Chronic Obstructive Pulmonary Disorder Sales Price Analysis
  5.2.4 China 2016 Chronic Obstructive Pulmonary Disorder Market Share Analysis
5.3 Europe Chronic Obstructive Pulmonary Disorder Market Analysis
  5.3.1 Europe Chronic Obstructive Pulmonary Disorder Market Overview
  5.3.2 Europe 2012-2017E Chronic Obstructive Pulmonary Disorder Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E Chronic Obstructive Pulmonary Disorder Sales Price Analysis
  5.3.4 Europe 2016 Chronic Obstructive Pulmonary Disorder Market Share Analysis
5.4 Southeast Asia Chronic Obstructive Pulmonary Disorder Market Analysis
  5.4.1 Southeast Asia Chronic Obstructive Pulmonary Disorder Market Overview
  5.4.2 Southeast Asia 2012-2017E Chronic Obstructive Pulmonary Disorder Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E Chronic Obstructive Pulmonary Disorder Sales Price Analysis
  5.4.4 Southeast Asia 2016 Chronic Obstructive Pulmonary Disorder Market Share Analysis
5.5 Japan Chronic Obstructive Pulmonary Disorder Market Analysis
  5.5.1 Japan Chronic Obstructive Pulmonary Disorder Market Overview
  5.5.2 Japan 2012-2017E Chronic Obstructive Pulmonary Disorder Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E Chronic Obstructive Pulmonary Disorder Sales Price Analysis
  5.5.4 Japan 2016 Chronic Obstructive Pulmonary Disorder Market Share Analysis
5.6 India Chronic Obstructive Pulmonary Disorder Market Analysis
  5.6.1 India Chronic Obstructive Pulmonary Disorder Market Overview
  5.6.2 India 2012-2017E Chronic Obstructive Pulmonary Disorder Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E Chronic Obstructive Pulmonary Disorder Sales Price Analysis
  5.6.4 India 2016 Chronic Obstructive Pulmonary Disorder Market Share Analysis

6 GLOBAL 2012-2017E CHRONIC OBSTRUCTIVE PULMONARY DISORDER SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E Chronic Obstructive Pulmonary Disorder Sales by Type
6.2 Different Types of Chronic Obstructive Pulmonary Disorder Product Interview Price Analysis
6.3 Different Types of Chronic Obstructive Pulmonary Disorder Product Driving Factors Analysis
  6.3.1 Short-Acting Bronchodilators of Chronic Obstructive Pulmonary Disorder Growth Driving Factor Analysis
  6.3.2 Corticosteroids of Chronic Obstructive Pulmonary Disorder Growth Driving Factor Analysis
  6.3.3 Methylxanthines of Chronic Obstructive Pulmonary Disorder Growth Driving Factor Analysis
  6.3.4 Long-Acting Bronchodilators of Chronic Obstructive Pulmonary Disorder Growth Driving Factor Analysis
  6.3.5 Phosphodiesterase-4 Inhibitors of Chronic Obstructive Pulmonary Disorder Growth Driving Factor Analysis

7 GLOBAL 2012-2017E CHRONIC OBSTRUCTIVE PULMONARY DISORDER SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E Chronic Obstructive Pulmonary Disorder Consumption by Application
7.2 Different Application of Chronic Obstructive Pulmonary Disorder Product Interview Price Analysis
7.3 Different Application of Chronic Obstructive Pulmonary Disorder Product Driving Factors Analysis
  7.3.1 Hospital Pharmacies of Chronic Obstructive Pulmonary Disorder Growth Driving Factor Analysis
  7.3.2 Retail Pharmacies of Chronic Obstructive Pulmonary Disorder Growth Driving Factor Analysis
  7.3.3 Online Pharmacies of Chronic Obstructive Pulmonary Disorder Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF CHRONIC OBSTRUCTIVE PULMONARY DISORDER

8.1 AstraZeneca
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 AstraZeneca 2016 Chronic Obstructive Pulmonary Disorder Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 AstraZeneca 2016 Chronic Obstructive Pulmonary Disorder Business Region Distribution Analysis
8.2 Boehringer Ingelheim
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Boehringer Ingelheim 2016 Chronic Obstructive Pulmonary Disorder Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Boehringer Ingelheim 2016 Chronic Obstructive Pulmonary Disorder Business Region Distribution Analysis
8.3 GSK
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 GSK 2016 Chronic Obstructive Pulmonary Disorder Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 GSK 2016 Chronic Obstructive Pulmonary Disorder Business Region Distribution Analysis
8.4 Novartis
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Novartis 2016 Chronic Obstructive Pulmonary Disorder Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Novartis 2016 Chronic Obstructive Pulmonary Disorder Business Region Distribution Analysis
8.5 Teva Pharmaceuticals
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Teva Pharmaceuticals 2016 Chronic Obstructive Pulmonary Disorder Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Teva Pharmaceuticals 2016 Chronic Obstructive Pulmonary Disorder Business Region Distribution Analysis
8.6 Ache Laboratorios Farmaceuticos
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Ache Laboratorios Farmaceuticos 2016 Chronic Obstructive Pulmonary Disorder Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Ache Laboratorios Farmaceuticos 2016 Chronic Obstructive Pulmonary Disorder Business Region Distribution Analysis
8.7 Almirall
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 Almirall 2016 Chronic Obstructive Pulmonary Disorder Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Almirall 2016 Chronic Obstructive Pulmonary Disorder Business Region Distribution Analysis
8.8 Aquinox Pharmaceuticals
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 Aquinox Pharmaceuticals 2016 Chronic Obstructive Pulmonary Disorder Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Aquinox Pharmaceuticals 2016 Chronic Obstructive Pulmonary Disorder Business Region Distribution Analysis
8.9 Ario Pharma
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Product A
    8.9.2.2 Product B
  8.9.3 Ario Pharma 2016 Chronic Obstructive Pulmonary Disorder Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 Ario Pharma 2016 Chronic Obstructive Pulmonary Disorder Business Region Distribution Analysis
8.10 Asmacure
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Product A
    8.10.2.2 Product B
  8.10.3 Asmacure 2016 Chronic Obstructive Pulmonary Disorder Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 Asmacure 2016 Chronic Obstructive Pulmonary Disorder Business Region Distribution Analysis
8.11 Astellas Pharma
8.12 BioMarck Pharmaceuticals

9 DEVELOPMENT TREND OF ANALYSIS OF CHRONIC OBSTRUCTIVE PULMONARY DISORDER MARKET

9.1 Global Chronic Obstructive Pulmonary Disorder Market Trend Analysis
  9.1.1 Global 2017-2022 Chronic Obstructive Pulmonary Disorder Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 Chronic Obstructive Pulmonary Disorder Sales Price Forecast
9.2 Chronic Obstructive Pulmonary Disorder Regional Market Trend
  9.2.1 North America 2017-2022 Chronic Obstructive Pulmonary Disorder Consumption Forecast
  9.2.2 China 2017-2022 Chronic Obstructive Pulmonary Disorder Consumption Forecast
  9.2.3 Europe 2017-2022 Chronic Obstructive Pulmonary Disorder Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 Chronic Obstructive Pulmonary Disorder Consumption Forecast
  9.2.5 Japan 2017-2022 Chronic Obstructive Pulmonary Disorder Consumption Forecast
  9.2.6 India 2017-2022 Chronic Obstructive Pulmonary Disorder Consumption Forecast
9.3 Chronic Obstructive Pulmonary Disorder Market Trend (Product Type)
9.4 Chronic Obstructive Pulmonary Disorder Market Trend (Application)

10 CHRONIC OBSTRUCTIVE PULMONARY DISORDER MARKETING TYPE ANALYSIS

10.1 Chronic Obstructive Pulmonary Disorder Regional Marketing Type Analysis
10.2 Chronic Obstructive Pulmonary Disorder International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Chronic Obstructive Pulmonary Disorder by Region
10.4 Chronic Obstructive Pulmonary Disorder Supply Chain Analysis

11 CONSUMERS ANALYSIS OF CHRONIC OBSTRUCTIVE PULMONARY DISORDER

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL CHRONIC OBSTRUCTIVE PULMONARY DISORDER MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Chronic Obstructive Pulmonary Disorder
Table Product Specifications of Chronic Obstructive Pulmonary Disorder
Table Classification of Chronic Obstructive Pulmonary Disorder
Figure Global Production Market Share of Chronic Obstructive Pulmonary Disorder by Type in 2016
Figure Short-Acting Bronchodilators Picture
Table Major Manufacturers of Short-Acting Bronchodilators
Figure Corticosteroids Picture
Table Major Manufacturers of Corticosteroids
Figure Methylxanthines Picture
Table Major Manufacturers of Methylxanthines
Figure Long-Acting Bronchodilators Picture
Table Major Manufacturers of Long-Acting Bronchodilators
Figure Phosphodiesterase-4 Inhibitors Picture
Table Major Manufacturers of Phosphodiesterase-4 Inhibitors
Table Applications of Chronic Obstructive Pulmonary Disorder
Figure Global Consumption Volume Market Share of Chronic Obstructive Pulmonary Disorder by Application in 2016
Figure Hospital Pharmacies Examples
Table Major Consumers of Hospital Pharmacies
Figure Retail Pharmacies Examples
Table Major Consumers of Retail Pharmacies
Figure Online Pharmacies Examples
Table Major Consumers of Online Pharmacies
Figure Market Share of Chronic Obstructive Pulmonary Disorder by Regions
Figure North America Chronic Obstructive Pulmonary Disorder Market Size (Million USD) (2012-2022)
Figure China Chronic Obstructive Pulmonary Disorder Market Size (Million USD) (2012-2022)
Figure Europe Chronic Obstructive Pulmonary Disorder Market Size (Million USD) (2012-2022)
Figure Southeast Asia Chronic Obstructive Pulmonary Disorder Market Size (Million USD) (2012-2022)
Figure Japan Chronic Obstructive Pulmonary Disorder Market Size (Million USD) (2012-2022)
Figure India Chronic Obstructive Pulmonary Disorder Market Size (Million USD) (2012-2022)
Table Chronic Obstructive Pulmonary Disorder Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Chronic Obstructive Pulmonary Disorder in 2016
Figure Manufacturing Process Analysis of Chronic Obstructive Pulmonary Disorder
Figure Industry Chain Structure of Chronic Obstructive Pulmonary Disorder
Table Capacity and Commercial Production Date of Global Chronic Obstructive Pulmonary Disorder Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Chronic Obstructive Pulmonary Disorder Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Chronic Obstructive Pulmonary Disorder Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Chronic Obstructive Pulmonary Disorder Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Chronic Obstructive Pulmonary Disorder 2012-2017
Figure Global 2012-2017E Chronic Obstructive Pulmonary Disorder Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Chronic Obstructive Pulmonary Disorder Market Size (Value) and Growth Rate
Table 2012-2017E Global Chronic Obstructive Pulmonary Disorder Capacity and Growth Rate
Table 2016 Global Chronic Obstructive Pulmonary Disorder Capacity (K Pcs) List (Company Segment)
Table 2012-2017E Global Chronic Obstructive Pulmonary Disorder Sales (K Pcs) and Growth Rate
Table 2016 Global Chronic Obstructive Pulmonary Disorder Sales (K Pcs) List (Company Segment)
Table 2012-2017E Global Chronic Obstructive Pulmonary Disorder Sales Price (USD/Pcs)
Table 2016 Global Chronic Obstructive Pulmonary Disorder Sales Price (USD/Pcs) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Pcs) of Chronic Obstructive Pulmonary Disorder 2012-2017E
Figure North America 2012-2017E Chronic Obstructive Pulmonary Disorder Sales Price (USD/Pcs)
Figure North America 2016 Chronic Obstructive Pulmonary Disorder Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Pcs) of Chronic Obstructive Pulmonary Disorder 2012-2017E
Figure China 2012-2017E Chronic Obstructive Pulmonary Disorder Sales Price (USD/Pcs)
Figure China 2016 Chronic Obstructive Pulmonary Disorder Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Pcs) of Chronic Obstructive Pulmonary Disorder 2012-2017E
Figure Europe 2012-2017E Chronic Obstructive Pulmonary Disorder Sales Price (USD/Pcs)
Figure Europe 2016 Chronic Obstructive Pulmonary Disorder Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Pcs) of Chronic Obstructive Pulmonary Disorder 2012-2017E
Figure Southeast Asia 2012-2017E Chronic Obstructive Pulmonary Disorder Sales Price (USD/Pcs)
Figure Southeast Asia 2016 Chronic Obstructive Pulmonary Disorder Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Pcs) of Chronic Obstructive Pulmonary Disorder 2012-2017E
Figure Japan 2012-2017E Chronic Obstructive Pulmonary Disorder Sales Price (USD/Pcs)
Figure Japan 2016 Chronic Obstructive Pulmonary Disorder Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Pcs) of Chronic Obstructive Pulmonary Disorder 2012-2017E
Figure India 2012-2017E Chronic Obstructive Pulmonary Disorder Sales Price (USD/Pcs)
Figure India 2016 Chronic Obstructive Pulmonary Disorder Sales Market Share
Table Global 2012-2017E Chronic Obstructive Pulmonary Disorder Sales (K Pcs) by Type
Table Different Types Chronic Obstructive Pulmonary Disorder Product Interview Price
Table Global 2012-2017E Chronic Obstructive Pulmonary Disorder Sales (K Pcs) by Application
Table Different Application Chronic Obstructive Pulmonary Disorder Product Interview Price
Table AstraZeneca Information List
Table Product A Overview
Table Product B Overview
Table 2016 AstraZeneca Chronic Obstructive Pulmonary Disorder Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 AstraZeneca Chronic Obstructive Pulmonary Disorder Business Region Distribution
Table Boehringer Ingelheim Information List
Table Product A Overview
Table Product B Overview
Table 2016 Boehringer Ingelheim Chronic Obstructive Pulmonary Disorder Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Boehringer Ingelheim Chronic Obstructive Pulmonary Disorder Business Region Distribution
Table GSK Information List
Table Product A Overview
Table Product B Overview
Table 2015 GSK Chronic Obstructive Pulmonary Disorder Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 GSK Chronic Obstructive Pulmonary Disorder Business Region Distribution
Table Novartis Information List
Table Product A Overview
Table Product B Overview
Table 2016 Novartis Chronic Obstructive Pulmonary Disorder Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Novartis Chronic Obstructive Pulmonary Disorder Business Region Distribution
Table Teva Pharmaceuticals Information List
Table Product A Overview
Table Product B Overview
Table 2016 Teva Pharmaceuticals Chronic Obstructive Pulmonary Disorder Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Teva Pharmaceuticals Chronic Obstructive Pulmonary Disorder Business Region Distribution
Table Ache Laboratorios Farmaceuticos Information List
Table Product A Overview
Table Product B Overview
Table 2016 Ache Laboratorios Farmaceuticos Chronic Obstructive Pulmonary Disorder Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Ache Laboratorios Farmaceuticos Chronic Obstructive Pulmonary Disorder Business Region Distribution
Table Almirall Information List
Table Product A Overview
Table Product B Overview
Table 2016 Almirall Chronic Obstructive Pulmonary Disorder Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Almirall Chronic Obstructive Pulmonary Disorder Business Region Distribution
Table Aquinox Pharmaceuticals Information List
Table Product A Overview
Table Product B Overview
Table 2016 Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disorder Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disorder Business Region Distribution
Table Ario Pharma Information List
Table Product A Overview
Table Product B Overview
Table 2016 Ario Pharma Chronic Obstructive Pulmonary Disorder Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Ario Pharma Chronic Obstructive Pulmonary Disorder Business Region Distribution
Table Asmacure Information List
Table Product A Overview
Table Product B Overview
Table 2016 Asmacure Chronic Obstructive Pulmonary Disorder Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Asmacure Chronic Obstructive Pulmonary Disorder Business Region Distribution
Table Astellas Pharma Information List
Table BioMarck Pharmaceuticals Information List
Figure Global 2017-2022 Chronic Obstructive Pulmonary Disorder Market Size (K Pcs) and Growth Rate Forecast
Figure Global 2017-2022 Chronic Obstructive Pulmonary Disorder Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Chronic Obstructive Pulmonary Disorder Sales Price (USD/Pcs) Forecast
Figure North America 2017-2022 Chronic Obstructive Pulmonary Disorder Consumption Volume (K Pcs) and Growth Rate Forecast
Figure China 2017-2022 Chronic Obstructive Pulmonary Disorder Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Europe 2017-2022 Chronic Obstructive Pulmonary Disorder Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Chronic Obstructive Pulmonary Disorder Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Japan 2017-2022 Chronic Obstructive Pulmonary Disorder Consumption Volume (K Pcs) and Growth Rate Forecast
Figure India 2017-2022 Chronic Obstructive Pulmonary Disorder Consumption Volume (K Pcs) and Growth Rate Forecast
Table Global Sales Volume (K Pcs) of Chronic Obstructive Pulmonary Disorder by Type 2017-2022
Table Global Consumption Volume (K Pcs) of Chronic Obstructive Pulmonary Disorder by Application 2017-2022
Table Traders or Distributors with Contact Information of Chronic Obstructive Pulmonary Disorder by Region